Answers are grounded in this paper and cite their sources.
Clinical overview highlights the emergence of sublingual immunotherapy for Japanese cedar pollinosis, suggesting a viable alternative to subcutaneous treatment.
Summary Immunotherapy is not generally used in Japan and very few medical institutions perform it. For radical treatment, immunotherapy should be selected. However, subcutaneous immunotherapy has not yet gained acceptance. Japanese cedar pollinosis is a seasonal allergic rhinitis that is indigenous to Japan and occurs with a nationwide mean prevalence of 25%. Clinical research on sublingual immunotherapy for Japanese cedar pollinosis has made progress and it should come into practical use within 2–3 years. If sublingual immunotherapy becomes practical, it should provide a new treatment option for Japanese cedar pollinosis.
No takes yet. Share an insight, caveat, or question.
Gotoh et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: